Literature DB >> 33111866

Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19.

Gustavo Luiz Gouvêa de Almeida Junior1, Fabricio Braga1, José Kezen Jorge1, Gustavo Freitas Nobre1, Marcelo Kalichsztein1, Paula de Medeiros Pache de Faria1, Bruno Bussade1, Guilherme Loures Penna1, Vitor Oliveira Alves1, Marcella Alecrim Pereira1, Paula de Castro Gorgulho1, Milena Rego Dos Santos Espelta de Faria1, Luis Eduardo Drumond1, Fabrini Batista Soares Carpinete1, Ana Carolina Lessa Brandão Neno1, Augusto César de Araújo Neno1.   

Abstract

BACKGROUND: COVID-19 causes severe pulmonary involvement, but the cardiovascular system can also be affected by myocarditis, heart failure and shock. The increase in cardiac biomarkers has been associated with a worse prognosis.
OBJECTIVES: To evaluate the prognostic value of Troponin-T (TNT) and natriuretic peptide (BNP) in patients hospitalized for Covid-19.
METHODS: This was a convenience sample of patients hospitalized for COVID-19. Data were collected from medical records to assess the association of TnT and BNP measured in the first 24 hours of hospital admission with the combined outcome (CO) of death or need for mechanical ventilation. Univariate analysis was used to compare the groups with and without the CO. Cox's multivariate model was used to determine independent predictors of the CO.
RESULTS: We evaluated 183 patients (age = 66.8±17 years, 65.6% of which were males). The time of follow-up was 7 days (range 1 to 39 days). The CO occurred in 24% of the patients. The median troponin-T and BNP levels were 0.011 and 0.041ng/dL (p <0.001); 64 and 198 pg/dL (p <0.001), respectively, for the groups without and with the CO. In the univariate analysis, in addition to TnT and BNP, age, presence of coronary disease, oxygen saturation, lymphocytes, D-dimer, t-CRP and creatinine, were different between groups with and without outcomes. In the bootstrap multivariate analysis, only TnT (1.12 [95% CI 1.03-1.47]) and t-CRP (1.04 [95% CI 1.00-1.10]) were independent predictors of the CO.
CONCLUSION: In the first 24h of admission, TnT, but not BNP, was an independent marker of mortality or need for invasive mechanical ventilation. This finding further reinforces the clinical importance of cardiac involvement in COVID-19. (Arq Bras Cardiol. 2020; 115(4):660-666).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33111866     DOI: 10.36660/abc.20200385

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  13 in total

Review 1.  Emerging biomarkers for the detection of cardiovascular diseases.

Authors:  Sreenu Thupakula; Shiva Shankar Reddy Nimmala; Haritha Ravula; Sudhakar Chekuri; Raju Padiya
Journal:  Egypt Heart J       Date:  2022-10-20

2.  Myocardial Injury Predicts Risk of Short-Term All-Cause Mortality in Patients With COVID-19: A Dose-Response Meta-Analysis.

Authors:  Yuehua Li; Hanjun Pei; Chenghui Zhou; Ying Lou
Journal:  Front Cardiovasc Med       Date:  2022-05-02

3.  Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times.

Authors:  Francesco Cannata; Sara Bombace; Giulio G Stefanini
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2021-01-21

4.  Cardiovascular Manifestations in the Pediatric Population with COVID-19, What is the Real Relevance?

Authors:  Andressa Mussi Soares; Bernardo Mussi Soares
Journal:  Arq Bras Cardiol       Date:  2021-11       Impact factor: 2.000

5.  Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients.

Authors:  Oluwabunmi Ogungbe; Baridosia Kumbe; Oluwadamilola Agnes Fadodun; T Latha; Diane Meyer; Adetoun Faith Asala; Patricia M Davidson; Cheryl R Dennison Himmelfarb; Wendy S Post; Yvonne Commodore-Mensah
Journal:  Int J Cardiol Heart Vasc       Date:  2022-01-04

6.  COVID-19 in patients with cardiac disease: Impact and variables associated with mortality in a cardiology center in Brazil.

Authors:  Mariah Rodrigues Paulino; José Alfredo de Sousa Moreira; Marcelo Goulart Correia; Léo Rodrigo Abrahão Dos Santos; Ingrid Paiva Duarte; Letícia Roberto Sabioni; Fabiana Bergamin Mucillo; Rafael Quaresma Garrido; Stephan Lachtermacher Pacheco; Andrea de Lorenzo; Cristiane da Cruz Lamas
Journal:  Am Heart J Plus       Date:  2021-11-20

7.  Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study.

Authors:  Issei Oi; Isao Ito; Masataka Hirabayashi; Kazuo Endo; Masahito Emura; Toru Kojima; Hitokazu Tsukao; Keisuke Tomii; Atsushi Nakagawa; Kojiro Otsuka; Masaya Akai; Masahiro Oi; Takakazu Sugita; Motonari Fukui; Daiki Inoue; Yoshinori Hasegawa; Kenichi Takahashi; Hiroaki Yasui; Kohei Fujita; Tadashi Ishida; Akihiro Ito; Hideo Kita; Yusuke Kaji; Michiko Tsuchiya; Hiromi Tomioka; Takashi Yamada; Satoru Terada; Hitoshi Nakaji; Nobuyoshi Hamao; Masahiro Shirata; Kensuke Nishioka; Masatoshi Yamazoe; Yusuke Shiraishi; Tatsuya Ogimoto; Kazutaka Hosoya; Hitomi Ajimizu; Hiroshi Shima; Hisako Matsumoto; Naoya Tanabe; Toyohiro Hirai
Journal:  Open Forum Infect Dis       Date:  2021-05-29       Impact factor: 3.835

8.  B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.

Authors:  Angelo Zinellu; Salvatore Sotgia; Ciriaco Carru; Arduino A Mangoni
Journal:  Front Cardiovasc Med       Date:  2021-06-24

9.  2020 Top 10 Original Articles in the Arquivos Brasileiros de Cardiologia and the Revista Portuguesa de Cardiologia.

Authors:  Ricardo Fontes-Carvalho; Gláucia Maria Moraes de Oliveira; Nuno Cardim; Carlos Eduardo Rochitte
Journal:  Arq Bras Cardiol       Date:  2021-06       Impact factor: 2.000

10.  Natriuretic Peptide Levels and Clinical Outcomes Among Patients Hospitalized With Coronavirus Disease 2019 Infection.

Authors:  M Imran Aslam; Anum Minhas; Anahita Ghorbani; Julie K Shade; Vivek Jani; Steven Hsu; Kavita Sharma; Daniela Cihakova; Allison G Hays; Nisha A Gilotra
Journal:  Crit Care Explor       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.